The Patent Finder

Antibody Libraries

Adimab, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2011/044063, filed Jul 14, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,138,478Antibody Libraries
In force
 · High confidence
Adimab, LLCIn force
High confidence
US 10,889,811Antibody Libraries
In force
 · High confidence
Adimab, LLCIn force
High confidence
US 12,018,403Antibody Libraries
In force
 · High confidence
Adimab, LLCIn force
High confidence
US 9,354,228Antibody Libraries
In force
 · High confidence
Adimab, LLCIn force
High confidence
Application 18/662,200Antibody Libraries
Pending
Not granted
Adimab, LLCPendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Adimab, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited